取消药品加成政策对57家县级公立医院医疗服务量的影响

doi:10.5246/jcps.2020.03.020

中国药学(英文版) ›› 2020, Vol. 29 ›› Issue (3): 220-226.DOI: 10.5246/jcps.2020.03.020

• 【药事管理与临床药学专栏】 • 上一篇

取消药品加成政策对57家县级公立医院医疗服务量的影响

聂智峰¹, 满春霞², 伊欣³, 刘伊³, 郭志刚^1,4, 管晓东^1,3, 史录文^1,3*

1. 北京大学医药管理国际研究中心, 北京 100191
2. 航天中心医院药剂科, 北京 100049
3. 北京大学医学部药学院药事管理与临床药学系, 北京 100191
4. 北京大学附属口腔医院药剂科, 北京 100081

收稿日期:2019-10-29 修回日期:2019-11-14 出版日期:2020-03-30 发布日期:2019-12-05
通讯作者: Tel.: +86-10-82805019, E-mail: shilu@bjmu.edu.cn

Impact of the zero-markup drug policy on volume of medical service: based on 57 county hospitals of China

Zhifeng Nie¹, Chunxia Man², Xin Yi³, Yi Liu³, Zhigang Guo^1,4, Xiaodong Guan^1,3, Luwen Shi^1,3*

1. International Research Center for Medicinal Administration, Peking University, Beijing 100191, China
2. Department of Pharmacy, Aerospace Center Hospital, Beijing 100049, China
3. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
4. Department of Pharmacy, Peking University School and Hospital of Stomatology, Beijing 100081, China

Received:2019-10-29 Revised:2019-11-14 Online:2020-03-30 Published:2019-12-05
Contact: Tel.: +86-10-82805019, E-mail: shilu@bjmu.edu.cn

摘要/Abstract

摘要：

本研究旨在评估取消药品加成政策对我国县级公立医院医疗服务量的长期影响。本研究采用57家县级公立医院2011–2015年医疗服务量的数据,以诊疗人次、门急诊处方量、出院患者人数、出院者占用总床日数、手术人次数、CT或MRI检查人次数为指标,通过固定效应面板回归,分析取消加成政策对县级公立医院医疗服务量的影响。实施取消药品加成政策的医院数量不断增加。截至2015年底, 41家医院(占样本医院总数的71.9%)实施了这一政策。面板回归显示,诊疗人次(P<0.01)、出院者占用总床日数(P<0.05)、手术人次数(P<0.01)、CT或MRI检查人次数(P<0.01)等各项指标均显著下降。然而,门急诊处方量和出院患者人数并没有显著变化。实施药品零加价政策可能会降低县级医院的医疗服务量。其原因还需要在今后的研究中进一步明确。

关键词: 取消药品加成, 医疗服务量, 县级公立医院, 中国

Abstract:

In the present study, we aimed to assess the long-term impact of zero-markup drug policy on volume of medical service in county hospitals of China. This study used 57 county hospitals’ records of medical service from 2011 to 2015, and a fixed effect model was applied to examine the impact of the zero-markup drug policy on volume of medical service. The outcome indicators included the number of patient visits, the number of prescriptions, the number of discharged patients, the length of stay, the number of patients who had surgeries and the number of patients who had CT or MRI, monthly. The number of hospitals which implementedthe zero-markup drug policy was increased continuously. By the end of 2015, 41 hospitals (71.9%) implemented this policy. The panel regression showed that most indicators were insignificantly decreased, including the number of patient visits (P<0.01), the length of stay (P<0.05), the number of patients who had surgeries (P<0.01) and the number of patients who had CT or MRI (P<0.01). However, the number of prescriptions and the number of discharged patients were not signiﬁcantly changed. The implementation of the zero-markup drug policy might affect the reduction of the volume of medical service in county-level hospitals and the reason needs to be clarified in future studies.

Key words: Zero-markup drug policy, Volume of medical service, County hospitals, China

中图分类号:

R951

Supporting:

聂智峰, 满春霞, 伊欣, 刘伊, 郭志刚, 管晓东, 史录文. 取消药品加成政策对57家县级公立医院医疗服务量的影响[J]. 中国药学(英文版), 2020, 29(3): 220-226.

Zhifeng Nie, Chunxia Man, Xin Yi, Yi Liu, Zhigang Guo, Xiaodong Guan, Luwen Shi. Impact of the zero-markup drug policy on volume of medical service: based on 57 county hospitals of China[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(3): 220-226.

参考文献

[1] Wu, Y. Discuss the reason and countermeasure of falsely high drug price. Qilu Pharm. Aff. 2005, 24, 122-123.

[2] National Health and Family Planning Commission of the PRC. China Health and Family Planning Statistical Yearbook 2016. Beijing, China: Peking Union Medical College Press. 2016, 102-105.

[3] The State Council of the People’s Republic of China. Opinions of the CPC Central Committee and the State Council on Deepening the Health Care System Reform. 2009. http://www.gov.cn/test/2009-04/08/content_1280069.htm.

[4] General Office of the State Council of the People’s Republic of China. Notice on the opinions on pilot comprehensive reform of county-level public hospitals issued by the general office of the state council. 2012. http://www.gov.cn/zwgk/2012-06/14/content_2161153.htm.

[5] The State Council of the People’s Republic of China. The general office of the state council issued opinions on the comprehensive reform of county-level public hospitals. 2015. http://www.gov.cn/zhengce/content/2015-05/08/content_9710.htm.

[6] The Ministry of Finance; National Development and Reform Commission; National Health and Family Planning Commission; State Administration of Traditional Chinese Dedicine; Ministry of Human Resources and Social Security; Office of the Central Agency Establishment Committee. Seven departments: notice on the comprehensive reform of public hospitals. 2017. http://www.gov.cn/xinwen/2017-04/29/content_5189918.htm#1.

[7] Sun, Q.; Tan, L.; Yang, L.; Zhao, W. Study on the personnel efficiency of county-level public hospitals after abolishing drug price plus in Sichuan province. China Health Industry. 2015, 03, 60-61.

[8] Chen, Q.; Wang, N.; Wang, J.L.; Liang, W.N. Influence of the implementation of selling drug without added profit on the development of Beijing community health service institutions. Chin. Gen. Pract. 2010, 34, 3842-3845.

[9] Tang, S.L.; Yang, J. Study on the impact of zero rate of essential drugs on community health service organizations -- a case study of community health service center in Suzhou. Price: Theory & Pract. 2012, 11, 27-28.

[10] Zhu, J.J.; Wang, W.J.; Jiang, Q.C. Analysis on the change of operation condition of primary medical institutions before and after zero-margin drug sales. Soft Sci. Health. 2012, 07, 641-643.

[11] Zhao, F.; Yang, L.; Zhang, X.G. Effect of separating drug sales from medical services on hospital revenue and medical services in the county public hospitals of Guangxi Province. Chin. J. Health Policy. 2015, 05, 24-30.

[12] Tian, W.; Yuan, J.F.; Yang, D.; Zhang, L.J. Descriptive analysis on the impacts of universal zero-markup drug policy on a Chinese urban tertiary hospital. PLoS One. 2016, 11, e0162795.

[13] Yi, H.M.; Miller, G.; Zhang, L.X.; Li, S.P.; Rozelle, S. Intended and unintended consequences of China’s zero markup drug policy. Health Aff. (Millwood) 2015, 34, 1391-1398.

[14] Jeffrey, M. Wooldridge. Introductory Econometrics: A Modern Approach. 4th ed. United States of America: South-Western Cengage Learning. 2008, 481-493.

[15] Cao, Y.H. Analysis of the economic operation under the comprehensive reform of public hospitals. China Chief Financial Officer. 2017, 4, 76-78.

[16] Tan, H.W.; Yang, G.; Yan, W.H.; Liu, X.; Zheng, W.H.; Zhang, Y.; Zhu, X.L.; Zhang, P.L. Study on the Rationality of Cancelling Drug Addition Compensation Strategy in County-level Public Hospitals in China. China Pharmacy. 2016, 27, 1301-1304.

[17] Ma, G.F.; Ma, A.N.; Yin, A.T.; Sheng, H.Q.; Wang, X.X.; Cheng, X.Z. Research on the Influences of County-level Hospital Comprehensive Reform Policy on Hospital Operation. Chin. Health Econ. 2014, 33, 17-20.

[18] Li, L.; Ye, L. The effect of zero-markup policy on drug cost in community health service centers. Health Econ. Res. 2012, 08, 30-34.

[19] Wu, M.; Mu, Y.; Liu, Y.; Yan, J.H.; He, Y.Q. Discussion on trend change and problem of medical health service ability in township hospitals — Based on comparison medical services amount of township hospitals in Shandong province from the year 2009 to 2015. Soft Sci. Health. 2018, 32, 16-19.

[20] Shen, R.S. Impact of drug zero-mark up sale reform on drug use in public hospital. Chin. Hosp. 2013, 17, 62-63.

取消药品加成政策对57家县级公立医院医疗服务量的影响

Impact of the zero-markup drug policy on volume of medical service: based on 57 county hospitals of China

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杜浩鑫, 保琦, 李黄倩玉, 张逸晨, 海沙尔江·吾守尔, 史录文, 管晓东. 中国中老年癌症幸存者健康状况分析[J]. 中国药学(英文版), 2023, 32(9): 744-754.
[2]	钱水莲, 徐欢, 刘文夏, 杨照, 江滨. 基于问卷调查的我国家庭储备药现况分析[J]. 中国药学(英文版), 2023, 32(1): 64-67.
[3]	北京大学药学院. 北京大学药学院李中军、董甦伟获中国化学会糖化学奖[J]. 中国药学(英文版), 2021, 30(5): 446-446.
[4]	李晓娇, 栾树鑫, 张洪, 万洪泉, 陈红, 刘成娇, 刘畅, 丁艳华. 单剂量长效利培酮注射液在中国精神分裂症患者体内的药代动力学、药效学和安全性研究[J]. 中国药学(英文版), 2021, 30(3): 206-217.
[5]	周越, 海沙尔江·吾守尔, 张翕, 冯佳佳, 林丽开, 郑波, 管晓东, 史录文. 2018年中国三级医院抗菌药物管理: 全国性横断面网络调查研究[J]. 中国药学(英文版), 2021, 30(12): 994-1007.
[6]	顾洁, 刘燕莉, 许风国, 张永泽, 邵蓉, 陆涛. 我国药学硕士专业学位教育的发展与挑战[J]. 中国药学(英文版), 2021, 30(1): 69-76.
[7]	北京大学药学院. 2019中国高被引科学家出炉, 药学院四位学者入选[J]. 中国药学(英文版), 2020, 29(5): 374-374.
[8]	王壮飞, 管晓东, 周越, 韩晟, 姚鹏, 史录文. 中国中老年人自我药疗发生率及影响因素研究：基于CHARLS 2011年, 2013年和2015年的面板数据[J]. 中国药学(英文版), 2019, 28(6): 430-438.
[9]	陈孝, 高翔, 陈杰, Sheryl L Chow, Moses S.S. Chow. 中国临床药学新方向: 采用“形式遵循功能”方式, 提高医疗保健效果[J]. 中国药学(英文版), 2018, 27(5): 352-360.
[10]	林向红, 胡豪, 刘伊, 管晓东, 宋佳芳, 史录文. 中国制药企业研发国际化的影响因素综合研究[J]. 中国药学(英文版), 2018, 27(3): 209-214.
[11]	柳欣. 2017年中国药物化学会中的北医药学人[J]. 中国药学(英文版), 2017, 26(9): 692-696.
[12]	张靖, 范潇予, 靳洪涛, 耿兴超. 中国药品非临床研究质量管理规范发展情况的回顾与展望[J]. 中国药学(英文版), 2017, 26(7): 534-544.
[13]	高宇雄, 丁黎, 梁文忠, 蒋华芳. UPLC-MS/MS同时测定人血浆中的丙酸氟替卡松与沙美特罗的方法学研究[J]. 中国药学(英文版), 2017, 26(4): 271-283.
[14]	《中国药学》(英文版). 《中国药学》(英文版)在“中国高校科技期刊研究会第21次年会”上获得多项奖励[J]. 中国药学(英文版), 2017, 26(11): 850-850.
[15]	姜勇. 北医药学院屠鹏飞、杨秀伟和吕万良三位教授入选 2015年中国高被引学者榜单[J]. 中国药学(英文版), 2016, 25(3): 228-229.